Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

… combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced …

mRNA Cancer Vaccines Show Early Clinical Promise

IASLC Announces New JTO CRR Editor-in-Chief

… Dr. Emily Stone will succeed JTO Clinical and Research Reports founding editor Dr. Alex A. Adjei, who will …

Recurrence Remains a Risk Even for Patients Diagnosed via Screening

… patients when guidelines and protocols vary and more research is needed. … Recurrence Remains a Risk Even for …

Mesothelioma Pioneer Delivers 2023 Heine H. Hansen Keynote Lecture

… honored for his significant contributions to lung cancer research during the 2023 European Lung Cancer Congress. … …

Final Poster Networking Reception Tonight

… this evening to talk with poster presenters about their research. … Final Poster Networking Reception Tonight … Erin …

US FDA Grants Breakthrough Therapy Designation for Novel TKI Targeting HER2, EGFR

… In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited …

Step it Up at WCLC 2025 in Barcelona

… audio. Participants can also support the IASLC’s future research initiatives and earn additional points by donating to …

More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care

… oncological surgery. Finally, oncology is the most active research field globally. constantly evolving treatment methods … summary, because of significant progress in oncological research for NSCLC, and because surgery is an early and …

2024 IASLC Academy to Once Again Compete in Amazing Case Race

… group of early career thoracic oncology clinicians and researchers has been a wonderful experience,” he said. …

Antibody Drug Conjugates: Diamonds in the Rough?

… the blood brain barrier, underscoring the need for more research into this phenomenon All in all, the future looks … TPS ≥50%: phase 3 KEYNOTE-D46/EVOKE-03 study. Cancer Research. 2023;83(8_Supplement):CT067-CT067. …